Abstract: Nail enamel compositions, particularly of the nitrocellulose type, have added a small amount of microcrystalline cellulose powder. When the compositions are applied to the nails, the microcrystalline cellulose particles act in lieu of long thin fibers to reinforce and strengthen the enamel coating while some of the particles tend to settle into the valleys between the nail ridges to smooth out the surface of the nails. These enamel compositions can be used without prior application of a filler coat to give a smooth, glossy, reinforced finish to the nails with no fibers visible.

Abstract: Hair removal compositions useful for cosmetic, medical and other purposes comprise 90 to 99.5% corn syrup and 0.5% to 10% added water by weight. The compositions can also include additives such as germicides, preservatives and opacifiers. The compositions are used by applying them to the surface of the skin in a hairy area, pressing a sheet of paper or other fibrous material against the area and subsequently lifting the sheet of fibrous material or peeling it off the skin surface. The compositions are also useful in removing blemishes and scaly, flaky or dry skin.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of cryptocidin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Ointment compositions for the treatment of styes and related infectious conditions of the eyelid. The ointments contain an emollient base, including white petrolatum, mineral oil and microcrystalline wax, as well as boric acid, wheat germ oil and mercuric oxide, the concentration of boric acid in the ointment is about 2-10% by weight, as is the concentration of the wheat germ oil, while the mercuric oxide is present in a concentration of about 1-1.2% by weight. The wheat germ oil enhances the anti-bacterial potency of the mercuric oxide, and the boric acid stabilizes the mercuric oxide in the presence of the wheat germ oil to prevent discoloration of the ointment.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of endomycin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: A nail polish that does not contain as a film-forming ingredient a potentially explosive nitrocellulose film former, and furthermore it does not contain formaldehyde or formaldehyde resin as a hardener which embrittles and dries the nails, and is non-allergenic and non-yellowing.The new nail polish contains ethyl methacrylate homopolymer of a molecular weight of approximately 25,000 as the film-forming ingredient, and includes as necessary modifiers cellulose acetate propionate of a viscosity of approximately 20 seconds (ASTM method D-1343), acetyl tributyl citrate, a mixture of sucrose esters and, optionally, camphor. In addition, the new nail polish contains organic volatile solvents and is essentially water free. It also may contain other additives commonly employed in nail polishes such as polyamide resins, thickeners, pearlescents, pigments, U.V. absorbers and fragrances.

Abstract: An improved nail polish composition for application to human nails which allows a polished nail to retain and absorb moisture thereby preventing brittleness and breakage of polished nails. Water and urea are used in the composition to impart moisture to the polished nail and polyvinyl butyral resin is used to harden the nail polish composition which is softened by the addition of water and to increase the adhesion of the nail polish composition to the nail.

Abstract: A nail cleanser containing sodium ethylenediamine tetraacetic acid, urea and water. When applied to nails it removes various stains such as tobacco, nail pigment, shoe polish, furniture polish and hair dyes.

Abstract: Orally administered compositions for treating benign prostatic hypertrophy are described herein. These compositions contain an effective dose of N-acyl amphotericin B. Also, the method of treating benign prostatic hypertrophy with such compositions is described herein.

Abstract: Orally administered compositions for altering liquid metabolism are described herein, these compositions containing an effective dose of n-acyl amphotericin B. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: A hair treatment composition simultaneously tones, shampoos and conditions hair in from about one to about three minutes. The composition includes henna material having a natural lawsone component and a natural fixer component, an aqueous-based carrier having an acidic pH, a non-toxic organic solvent for extracting quantities of the natural lawsone and fixer components from the henna material, synthetic lawsone for making more coloring principle available, a fixing agent cooperating with the natural fixer component for fixing the natural lawsone component and/or synthetic lawsone to the hair, cleaning agents for shampooing the hair, and conditioning agents for conditioning the hair.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein. These compositions containing an effective dose of candimycin. Also, the method of treating prostatic hypertrophy with such compositions is described herein.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of candimycin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of heptamycin. Also, the method of treating prostatic hypertrophy with such compositions is described herein.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of antibiotic SCH-16656. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level is described herein.

Abstract: A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide selected from the class consisting of candicidin, fungimycin, hamycin and mediocidin is described which comprises orally administering the polyenic macrolide with an absorbent material. Compositions containing a polyenic macrolide and a suitable absorbent material preferably in beadlet form are described for use in treating various conditions including prostate hypertrophy, hypercholesterolemia and acne.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of Levorin. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.

Abstract: Orally administered compositions for treating prostatic hypertrophy are described herein. These compositions contain an effective dose of a pharmaceutical formulation containing antibiotic SCH-16656. Also, the method of treating prostatic hypertrophy with such compositions is described herein.

Abstract: A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide selected from the class consisting of candicidin, fungimycin, hamycin and mediocidin is described which comprises orally administering the polyenic macrolide with an absorbent material. Compositions containing a polyenic macrolide and a suitable absorbent material preferably in beadlet form are described for use in treating various conditions including prostate hypertrophy, hypercholesterolemia and acne.

Abstract: Orally administered compositions for altering lipid metabolism are described herein, these compositions containing an effective dose of a pharmaceutical formulation having a molecular structure including a polyenic macrolide nucleus having at least five conjugated double bonds. Also the method of altering lipid metabolism including reducing and controlling the blood cholesterol level, is described herein.